FCGR2A/FCGR3A Gene Polymorphisms and Clinical Variables as Predictors of Response to Tocilizumab and Rituximab in Patients With Rheumatoid Arthritis

  1. Jiménez Morales, A.
  2. Maldonado-Montoro, M.
  3. Martínez de la Plata, J.E.
  4. Pérez Ramírez, C.
  5. Daddaoua, A.
  6. Alarcón Payer, C.
  7. Expósito Ruiz, M.
  8. García Collado, C.
Zeitschrift:
Journal of Clinical Pharmacology

ISSN: 1552-4604 0091-2700

Datum der Publikation: 2019

Ausgabe: 59

Nummer: 4

Seiten: 517-531

Art: Artikel

DOI: 10.1002/JCPH.1341 GOOGLE SCHOLAR